Toxic effects of silver nanoparticles and nanowires on erythrocyte rheology

Food and Chemical Toxicology

Volumn 67, Issue , 2014, Pages 80-86

  Kim, Min Jung ^a   Shin, Sehyun ^a  

^a Korea University   (South Korea)

Author keywords

Blood; Deformability; Hemorheology; Silver nanoparticles; Silver nanowires; Toxicology

Indexed keywords

NANOWIRE; SILVER; SILVER NANOPARTICLE; METAL NANOPARTICLE;

ARTICLE; BLOOD RHEOLOGY; BLOOD TOXICITY; CONCENTRATION (PARAMETERS); ERYTHROCYTE; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE STRUCTURE; HEMOLYSIS; HUMAN; HUMAN CELL; INCUBATION TIME; PARTICLE SIZE; RISK ASSESSMENT; SCANNING ELECTRON MICROSCOPY; CHEMISTRY; DRUG EFFECTS; FLOW KINETICS; TOXICITY; ULTRASTRUCTURE;

ERYTHROCYTES; HUMANS; METAL NANOPARTICLES; MICROSCOPY, ELECTRON, SCANNING; NANOWIRES; RHEOLOGY; SILVER;

EID: 84896082457     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2014.02.006     Document Type: Article

References (31)

1. Agroyannis B., Dalamangas A., Tzanatos H., Fourtounas C., Kopelias I., Konstadinidou I., Koutsikos D. Are alterations of protein 4.1 involved in the echinocytic transformation of red blood cells?. Blood 1994, 84:1685-1686.
2. Asharani P.V., Mun G.L.K., Hande M.P., Valiyaveettil S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 2009, 3:279-290.
3. Asharani P.V., Sethu S., Vadukumpully S., Zhong S., Lim C.T., Hande M.P., Valiyaveettil S. Investigations on the structural damage in human erythrocytes exposed to silver, gold, and platinum nanoparticles. Adv. Funct. Mater. 2010, 20:1233-1242.
4. Baskurt O.K., Boynard M., Cokelet G.C., Connes P., Cooke B.M., Forconi S., Liao F., Hardeman M.R., Jung F., Meiselman H.J., Nash G., Nemeth N., Neu B., Sandhagen B., Shin S., Thurston G., Wautier J.L. New guidelines for hemorheological laboratory techniques. Clin. Hemorheol. Microcirc. 2009, 42:75-97.
5. Baskurt O.K., Neu B., Meiselman H. Red Blood Cell Aggregation 2011, CRC Press, pp. 55-58.
6. Bouwmeester H., Poortman J., Peters R.J., Wijma E., Kramer E., Makama S., Puspitaninganindita K., Marvin H.J.P., Peijnenburg A.C.M., Hendriksen P.J.M. Characterization of translocation of silver nanoparticles and effects on whole-genome gene expression using an in vitro intestinal epitheliumamp coculture model. ACS Nano 2011, 5:4091-4103.
7. Bussy C., Methven L., Kostarelos K. Hemotoxicity of carbon nanotubes. Adv. Drug Delivery Rev. 2013, 65:2127-2134.
8. Buzea C., Pacheco II., Robbie K. Nanomaterials and nanoparticles: sources and toxicity. Biointerphases 2007, 2:MR17-MR71.
9. Choi J.H., Reipa V., Hitchins V.M., Goering P.L., Malinauskas R.A. Physicochemical characterization and in vitro hemolysis evaluation of silver nanoparticles. Toxicol. Sci. 2011, 123:133-143.
10. Clark M.R., Mohandas N., Feo C., Jacobs M.S., Shohet S.B. Separate mechanisms of deformability loss in ATP-depleted and Ca-loaded erythrocytes. J. Clin. Invest. 1981, 67:531-539.
11. Cockburn A., Bradford R., Buck N., Constable A., Edwards G., Haber B., Hepburn P., Howlett J., Kampers F., Klein C., Radomski M., Stamm H., Wijnhoven S., Wildemann T. Approaches to the safety assessment of engineered nanomaterials (ENM) in food. Food Chem. Toxicol. 2012, 50:2224-2242.
12. Jun E.-A., Lim K.-M., Kim K. Silver nanoparticles enhance thrombus formation through increased platelet aggregation and procoagulant activity. Nanotoxicology 2011, 5(2):157-167.
13. Kim C.B., Shin S., Song S.H. Hemorheological changes caused by lead exposure. Clin. Hemorheol. Microcirc. 2013, 55:341-348.
14. 2 nanoparticles to erythrocyte in vitro. Food Chem. Toxicol. 2008, 46:3626-3631.
15. Neas L.M. Fine particulate matter and cardiovascular disease. Fuel Process. Technol. 2000, 65-66:55-67.
16. Neu B., Sowemimo-Coker S.O., Meiselman H.J. Cell-cell affinity of senescent human erythrocytes. Biophys. J. 2003, 85:75-84.
17. Panyala N.R., Pena-Mendez E.M., Havel J. Silver or silver nanoparticles: a hazardous threat to the environment and human health?. J. Appl. Biomed. 2008, 6:117-129.
18. Peters A., Veronesi B., Calderon-Garciduenas L., Gehr P., Chen L.C., Geiser M., Reed W., Rothen-Rutishauser B., Schurch S., Schulz H. Translocation and potential neurological effects of fine and ultrafine particles a critical update. Part. Fibre Toxicol. 2006, 3:13.
19. Powell M.C., Kanarel M.S. Nanomaterial health effects-Part 2: uncertainties and recommendations for future. Wisconsin Med. J. 2006, 105:18-23.
20. Sachar S., Saxena R.K., 2011. Cytotoxic Effect of Poly-Dispersed Single Walled Carbon Nanotubes on Erythrocytes In Vitro and In Vivo, PLoS ONE. http://dx.doi.org/10.1371/journal.pone.0022032.
21. Shin S., Hou J.X., Suh J.S., Singh M. Validation and application of a microfluidic ektacytometer (RheoScan-D) in measuring erythrocyte deformability. Clin. Hemorheol. Microcirc. 2007, 37:319-328.
22. Shin S., Ku Y.-H., Ho J.-X., Kim Y.-K., Suh J.-S., Singh M. Progressive impairment of erythrocyte deformability as indicator of microangiopathy in type 2 diabetes mellitus. Clin. Hemorheol. Microcirc. 2007, 36:253-261.
23. Shin S., Yang Y., Suh J.-S. Measurement of erythrocyte aggregation in a microchip stirring system by light transmission. Clin. Hemorheol. Microcirc. 2009, 41:197-207.
24. Shrivastava S., Bera T., Roy A., Singh G., Ramachandrarao P., Dash D. Characterization of enhanced antibacterial effects of novel silver nanoparticles. Nanotechnology 2007, 18:225103.
25. Smock K.J., Schmidt R.L., Hadlock G., Stoddard G., Grainger D.W., Munger M.A. Assessment of orally dosed commercial silver nanoparticles on human ex vivo platelet aggregation. Nanotoxicology 2013, 8:328-333.
26. Thurn K.T., Brown E.M.B., Wu A., Vogt S., Lai B., Maser J., Paunesku T., Woloschak G.E. Nanoparticles for applications in cellular imaging. Nanoscale Res. Lett. 2007, 2:430-441.
27. Wang H., Qiao X., Chen J., Wang X., Ding S. Mechanisms of PVP in the preparation of silver nanoparticles. Mater. Chem. Phys. 2005, 94:449-453.
28. Wijnhoven S.W.P., Peijnenburg W.J.G.M., Herberts C.A., Hagens W.I., Oomen A.G., Heugens E.H.W., Roszek B., Bisschops J., Gosens I., Van De Meent D. Nano-silver-a review of available data and knowledge gaps in human and environmental risk assessment. Nanotoxicology 2009, 3:109-138.
29. Xue S., Lee B.-K., Shin S. Disaggregating shear stress: the roles of cell deformability and fibrinogen concentration. Clin. Hemorheol. Microcirc. 2013, http://dx.doi.org/10.3233/CH-2012-1627.
30. Zhao Y., Sun X., Zhang G., Trewyn B.G., Slowing I.I., Lin V.S.-Y. Interaction of mesoporous silica nanoparticles with human red blood cell membranes: size and surface effects. ACS Nano 2011, 5:1366-1375.
31. Zook J.M., MacCuspie R.I., Locascio L.E., Halter M.D., Elliott J.T. Stable nanoparticle aggregates/agglomerates of different sizes and the effect of their size on hemolytic cytotoxicity. Nanotoxicology 2011, 5:517-530.